INVESTMENT SCOPE
Identifying Promising Start-ups and Cutting-edge Technologies
CVF is a strategic corporate investment fund. We want to invest in promising management teams and great science that align with Chugai Pharmaceuticals’ R&D efforts. We are investors committed to a long-term view. The typical investment size is mid-single million dollars with reserves for follow-on investments. We are looking at early-stage science and companies.
CVF wants to invest in preclinical companies in the areas of:
New target identification
Platform technologies that apply to multiple therapeutic areas
Therapeutics companies that are aligned with Chugai Pharmaceuticals’ core areas of research
Our investment areas
of interest are
Oncology
Immunology
CNS
Ophthalmology
Metabolic Diseases
Rare Diseases